2-[(8S,11S)-11-{(1R)-1-Hydroxy-2-[(3-methylbutyl)(phenylsulfonyl)amino]ethyl}-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-8-yl]acetamide

2-(11-{2-[BENZENESULFONYL-(3-METHYL-BUTYL)-AMINO]-1-HYDROXY-ETHYL}-6,9-DIOXO-2-OXA-7,10-DIAZA-BICYCLO[11.2.2]HEPTADECA-1(16),13(17),14-TRIEN-8-YL)-ACETAMIDE, INHIBITOR 2

2-[(8S,11S)-11-{(1R)-1-Hydroxy-2-[(3-methylbutyl)(phenylsulfonyl)amino]ethyl}-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-8-yl]acetamid

2-[(8S,11S)-11-{(1R)-1-Hydroxy-2-[(3-methylbutyl)(phenylsulfonyl)amino]ethyl}-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-8-yl]acetamide

2-[(8S,11S)-11-{(1R)-1-Hydroxy-2-[(3-méthylbutyl)(phénylsulfonyl)amino]éthyl}-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadéca-1(15),13,16-trién-8-yl]acétamide

2-Oxa-7,10-diazabicyclo[11.2.2]heptadeca-13,15,16-triene-8-acetamide, 11-[(1R)-1-hydroxy-2-[(3-methylbutyl)(phenylsulfonyl)amino]ethyl]-6,9-dioxo-, (8S,11S)-

2-(3-{(1R)-1-Hydroxy-2-[(3-methylbutyl)(phenylsulfonyl)amino]ethyl}(3S,6S)-4,7-diaza-12-oxa-5,8-dioxobicyclo[11.2.2]heptadeca-1(15),13,16-trien-6-yl)acetamide

2-[(8S,11S)-11-[(1R)-1-hydroxy-2-[N-(3-methylbutyl)benzenesulfonamido]ethyl]-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-8-yl]acetamide

2-[(8S,11S)-11-{(1R)-1-HYDROXY-2-[ISOPENTYL(PHENYLSULFONYL)AMINO]ETHYL}-6,9-DIOXO-2-OXA-7,10-DIAZABICYCLO[11.2.2]HEPTADECA-1(15),13,16-TRIEN-8-YL]ACETAMIDE

Gag-Pol polyprotein

HBH

Macrocyclic Peptidomimetic Inhibitor 2

POL_HV1BR